L-Glutamic acid hydrochloride
Common Name: |
L-Glutamic acid hydrochloride |
IUPAC Name: |
(2S)-2-aminopentanedioic acid;hydrochloride |
Molecular Formula: |
C5H10ClNO4 |
SMILES: |
C(CC(=O)O)[C@@H](C(=O)O)N.Cl |
Inchi: |
1S/C5H9NO4.ClH/c6-3(5(9)10)1-2-4(7)8;/h3H,1-2,6H2,(H,7,8)(H,9,10);1H/t3-;/m0./s1 |
Inchi Key: |
RPAJSBKBKSSMLJ-DFWYDOINSA-N |
Cas No: |
138-15-8 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
159.98 |
Mass (g/mol) |
183.03 |
Molar Refractivity |
18.85 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
0 |
Rings |
|
TPSA |
40.13 |
Hetero Atoms |
|
Heavy Atoms |
6 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
214.00 |
Boiling Point (°C@760.00mm Hg) |
333.80 |
Vapor Pressure (mmHg@25.00 °C) |
0.000025 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
|
iLOGP |
0.00 |
XLOGP3 |
-0.07 |
WLOGP |
0.55 |
MLOGP |
-1.30 |
ESOL Log S |
-0.79 |
ESOL Solubility (mg/ml) |
26.1 |
ESOL Solubility (mol/l) |
0.163 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-0.32 |
Ali Solubility (mg/ml) |
76.3 |
Ali Solubility (mol/l) |
0.48 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-0.22 |
Silicos-IT Solubility (mg/ml) |
96.4 |
Silicos-IT Solubility (mol/l) |
0.6 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-7.33 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
0 |
Plasm Protein Binding |
0.036 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.772 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |